Abstract
Communication between the mitochondrial and nuclear genomes is vital for cellular function. The assembly of mitochondrial enzyme complexes that produce the majority of cellular energy requires the coordinated expression and translation of both mitochondrial and nuclear encoded proteins. The joint genetic architecture of this system complicates the basis of mitochondrial diseases, and mutations in both mtDNA- and nuclear-encoded genes have been implicated in mitochondrial dysfunction. Previously, in a set of mitochondrial-nuclear introgression strains we characterized a dual genome epistasis in which a naturally occurring mutation in the D. simulans simw501 mtDNA-encoded tRNA for tyrosine interacts with a mutation in the nuclear encoded mitochondrial localized tyrosyl-tRNA synthetase from D. melanogaster. Here we show that the incompatible mitochondrial-nuclear combination results in locomotor defects, reduced mitochondrial respiratory capacity, decreased OXPHOS enzyme activity, and severe alterations in mitochondrial morphology. Transgenic rescue strains containing nuclear variants of the tyrosyl-tRNA synthetase are sufficient to rescue many of the deleterious phenotypes identified when paired with the simw501 mtDNA. However, the severity of this defective mito-nuclear interaction varies across traits and genetic backgrounds, suggesting that the impact of mitochondrial dysfunction may be tissue specific. Because mutations in mitochondrial tRNATyr are associated with exercise intolerance in humans, this mitochondrial-nuclear introgression model in Drosophila provides a means to dissect the molecular basis of these, and other mitochondrial diseases that are a consequence of the joint genetic architecture of mitochondrial function.
- Received December 2, 2014.
- Accepted April 23, 2015.
- © 2015. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
Editor’s choice – Identification of cardioprotective drugs in a Drosophila model of Friedreich's ataxia
Véronique Monnier and colleagues describe a drug screening approach in a Drosophila model of Friedreich's ataxia. This study demonstrates that cardiac functional imaging in adult flies is feasible for in vivo pharmacological screening of candidate cardioprotective compounds.
Review – Probiotics against airway allergy: host factors to consider
In a new Review, Sarah Lebeer and colleagues discuss the host factors that influence the outcomes of in vivo probiotic interventions in allergy, focusing on genetics, sex, age and microbiological status in mouse models of allergic disease.
Special issue - Cancer metabolism
Recent years have brought about a resurgent interest in cancer metabolism. To showcase the recent advances in the field, DMM are currently compiling a special issue, Cancer metabolism: models, mechanisms and targets, guest edited by Almut Schulze and Mariia Yuneva. As the special issue continues to grow, we will showcase the key highlights here.
Model for life – Finding clues in the p53 maze
To open the issue, we spoke to Prof. Karen Vousden about how she came to focus on the many functions of tumour suppressor protein p53 in cancer and beyond.
Review – The metabolic axis of macrophage and immune cell polarization
A new Review by Spencer Hobson-Gutierrez and Carlos Carmona-Fontaine summarises how metabolic cues in the tumour microenvironment affect the immune system, with a special focus on tumour-associated macrophages.
First Person interviews
Have you seen our interviews with the early-career first authors of our papers? Recently, we caught up with first authors Soo-Hyun Kim, Diana Papazova, Genki Hayashi, Ricardo Mondragon-Gonzalez, Derek Erstad and Nelly El-Sakkary
Why should you publish your next paper in DMM?
DMM aims to promote human health by encouraging collaboration between basic and clinical researchers, covering a diverse range of diseases, approaches and models. Our Editors are all active researchers in the field – your peers, colleagues and mentors, who know how much work has gone into every paper. Recently, we have introduced format-free submission, and we accept peer review reports from other journals, making submission as easy as possible for our authors. Send us your next great paper – publish with us and you'll be in good company.
preLights – From GWAS to function
Daniel Grimes highlights a recent preprint from Alexander F. Schier and colleagues, describing a phenotypic atlas of 132 zebrafish mutants to shed light on the role of human schizophrenia-associated genes.
We are pleased to announce that DMM now features recent preLights of interest to the translational biology community as part of each issue's Table of Contents.